Pharmaceutical composition
AssigneeKowa Company, Ltd.
InventorsKentaro Mikami, Rie Ishida, Takashi Nakagawa
Life of this patent
Estimating the term…
Abstract
[Problem to be solved] The present invention addresses the problem of providing a pharmaceutical composition for the prevention and/or treatment of diseases related to pulmonary fibrosis. [Solution] Provided is a pharmaceutical composition for the prevention and/or treatment of diseases involving pulmonary fibrosis, in which the active ingredient is 3-[2-(5-{[1-(5-ethoxypyrimidin-2-yl)-2-isopropyl-6-oxo-4-propyl-1,6-dihydropyrimidin-5-yl]methyl}pyridin-2-yl)phenyl]-1,2,4-oxadiazol-5(4H)-one, or a salt thereof, or a solvate of these.
Claims6
A pharmaceutical composition comprising 3-[2-(5-{[1-(5-ethoxypyrimidin-2-yl)-2-isopropyl-6-oxo-4-propyl-1,6-dihydropyrimidin-5-yl]methyl}pyridin-2-yl)phenyl]-1,2,4-oxadiazol-5(4H)-one, a salt, a solvate or a solvate of the salt thereof for preventing and/or treating a pulmonary fibrosis related disorder.
Dependencies are inferred from the claim text.